For research use only. Not for therapeutic Use.
CP-724714 (Cat.No:I003412) is a small molecule inhibitor that targets the tyrosine kinase activity of the platelet-derived growth factor receptor (PDGFR). It has shown efficacy in inhibiting tumor growth and angiogenesis in preclinical studies. Further research is needed to evaluate its potential as an anti-cancer therapeutic agent.
Catalog Number | I003412 |
CAS Number | 383432-38-0 |
Synonyms | 2-methoxy-N-[(2E)-3-[4-[[3-methyl-4-[(6-methyl-3-pyridinyl)oxy]phenyl]amino]-6-quinazolinyl]-2-propen-1-yl]-acetamide |
Molecular Formula | C27H27N5O3 |
Purity | ≥95% |
Target | HER2/ErbB2 |
Solubility | DMSO: ≥ 50 mg/mL |
Storage | Store at -20°C |
IC50 | 10 nM [1] |
IUPAC Name | 2-methoxy-N-[(E)-3-[4-[3-methyl-4-(6-methylpyridin-3-yl)oxyanilino]quinazolin-6-yl]prop-2-enyl]acetamide |
InChI | InChI=1S/C27H27N5O3/c1-18-13-21(8-11-25(18)35-22-9-6-19(2)29-15-22)32-27-23-14-20(7-10-24(23)30-17-31-27)5-4-12-28-26(33)16-34-3/h4-11,13-15,17H,12,16H2,1-3H3,(H,28,33)(H,30,31,32)/b5-4+ |
InChIKey | LLVZBTWPGQVVLW-SNAWJCMRSA-N |
SMILES | O=C(COC)NC/C=C/C1=CC=C(N=CN=C2NC3=CC=C(OC4=CN=C(C)C=C4)C(C)=C3)C2=C1 |
Reference | <p style=/line-height:25px/> |